IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 171 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $798 | +49.2% | 175,417 | +130.7% | 0.00% | – |
| Q2 2023 | $535 | +271.5% | 76,042 | +222.5% | 0.00% | – |
| Q1 2023 | $144 | -95.2% | 23,576 | +6733.6% | 0.00% | – |
| Q3 2022 | $3,000 | -99.3% | 345 | -98.7% | 0.00% | – |
| Q1 2022 | $441,000 | -58.0% | 26,505 | -51.8% | 0.00% | -100.0% |
| Q4 2021 | $1,049,000 | – | 54,976 | +432.4% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 10,327 | -16.4% | 0.00% | -100.0% |
| Q3 2020 | $406,000 | -45.4% | 12,359 | -50.3% | 0.00% | 0.0% |
| Q1 2020 | $744,000 | +11.7% | 24,875 | +3.4% | 0.00% | 0.0% |
| Q4 2019 | $666,000 | +166.4% | 24,066 | +75.1% | 0.00% | 0.0% |
| Q3 2019 | $250,000 | -46.9% | 13,743 | -28.6% | 0.00% | 0.0% |
| Q2 2019 | $471,000 | +2378.9% | 19,235 | +788.9% | 0.00% | – |
| Q4 2018 | $19,000 | +72.7% | 2,164 | +116.4% | 0.00% | – |
| Q3 2018 | $11,000 | -94.8% | 1,000 | -93.9% | 0.00% | -100.0% |
| Q2 2018 | $210,000 | -73.0% | 16,429 | -64.4% | 0.00% | -97.1% |
| Q1 2018 | $779,000 | +5892.3% | 46,119 | +2485.1% | 0.03% | +3300.0% |
| Q3 2017 | $13,000 | -66.7% | 1,784 | -66.5% | 0.00% | -50.0% |
| Q2 2017 | $39,000 | – | 5,325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |